We focus on the transfer of new technologies into practice. We are dedicated to innovations in the field of Drug Discovery, Diagnostics, MedTech and other Life Science fields originating from academic institutions. Our team supports the creation of spin-off companies and the sale of licenses.
We scout and support the growth through discovery, pre-seed or seed phase of the most promising projects with innovative potential in Drug Discovery, Diagnostics, MedTech and other Life Science fields.
Our ambition is to become a leading partner advancing and promoting game-changing biotech inventions coming from the Central Europe region.
Our team benefits from expertise and experience gathered from IOCB and IOCB Tech. We are developing a pool of highly promising biotech projects originating from academia and finding commercial partners for them.
We operate as a private company under the wings of the Czech Academy of Sciences and its Institute of Organic Chemistry and Biochemistry (IOCB). From 1994 to 2002, the IOCB was led by Dr. Antonín Holý, whose team invented and developed hugely effective and successful anti-HIV drugs (Truvada, Atripla, Complera, Eviplera). We believe that this is a legacy to build upon and that, with your and our combined expertise, we can make this world a better place and help millions of people.
Meet Our Team
Our team benefits from decades of know-how and experiences gathered in academic institutions, technology transfer and industrial companies. Using this knowledge, we are developing a pool of highly potent biotech projects originating in academia and finding commercial partners for them.